Oliwia Borowska
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Oliwia Borowska has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Barbara Wardzyńska
Independent Public Healthcare Complex in Wyszków, Komisji Edukacji Narodowej 1, 07-200 Wyszków, Poland
3 shared publications - Eliza MęDrek
Nowy Dwór Mazowiecki Medical Center, Miodowa 2, 05-100 Nowy Dwór Mazowiecki, Poland
3 shared publications - Hanna Markowska
Samodzielny Publiczny Wielospecjalistyczny Zakład Opieki Zdrowotnej Ministerstwa Spraw Wewnętrznych i Administracji w Bydgoszczy, Poland
3 shared publications - Jakub Magdziak
Independent Public Clinical Hospital named after Prof. W. Orłowski, CMKP, Czerniakowska 231, 00-416 Warsaw, Poland
3 shared publications - Natalia Brzozowska
Nowy Dwór Mazowiecki Medical Center, Miodowa 2, 05-100 Nowy Dwór Mazowiecki, Poland
3 shared publications - Natalia Sałkowska
University Clinical Center of the Medical University of Warsaw, Banacha 1a, 02-097 Warsaw, Poland
3 shared publications
Latest Publications
- Open Access
- 21 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (3(51))
VITAMIN D3 AND CANCER PREVENTION: FROM BIOLOGICAL MECHANISM TO CLINICAL EVIDENCE
Vitamin D3 (cholecalciferol) is a steroid prohormone synthesized in the skin as a result of UV-B light exposure or by dietary intake. In addition to the already proven action on calcium phosphate metabolism and bone physiology, there is an increasing body of research showing that vitamin D3 may impact carcinogenesis and cancer progression. The aim of this literature review was to summarize current knowledge regarding the biological mechanisms of vitamin D₃ and its potential impact on cancer risk, progression, and patient survival. Multiple observational trials have confirmed that there is an inverse relationship between levels of serum 25-hydroxyvitamin D [25(OH)D] and the risk as well as mortality rates associated with some types of cancer, especially colorectal and breast cancers. However, findings from randomized controlled trials evaluating primary cancer prevention remain inconclusive. Such contradicting findings have been linked to limitations in research design, which include insufficient supplementation doses, inclusion of participants with adequate baseline vitamin D status, and relatively short follow-up periods. Vitamin D exerts its action via the vitamin D receptor (VDR) at the molecular level. It affects the gene expression related to various functions such as the cell cycle, apoptosis, cellular differentiation, immune modulation, and inflammatory processes. Current scientific evidence supports a mechanism by which vitamin D3 could play a part in the prevention of cancer. However, clear clinical recommendations require further well-designed randomized controlled trials incorporating adequate supplementation doses and focusing on populations with vitamin D deficiency.
- 21 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (3(51))
Open AccessVITAMIN D3 AND CANCER PREVENTION: FROM BIOLOGICAL MECHANISM TO CLINICAL EVIDENCE
Vitamin D3 (cholecalciferol) is a steroid prohormone synthesized in the skin as a result of UV-B light exposure or by dietary intake. In addition to the already proven action on calcium phosphate metabolism and bone physiology, there is an increasing body of research showing that vitamin D3 may impact carcinogenesis and cancer progression. The aim of this literature review was to summarize current knowledge regarding the biological mechanisms of vitamin D₃ and its potential impact on cancer risk, progression, and patient survival. Multiple observational trials have confirmed that there is an inverse relationship between levels of serum 25-hydroxyvitamin D [25(OH)D] and the risk as well as mortality rates associated with some types of cancer, especially colorectal and breast cancers. However, findings from randomized controlled trials evaluating primary cancer prevention remain inconclusive. Such contradicting findings have been linked to limitations in research design, which include insufficient supplementation doses, inclusion of participants with adequate baseline vitamin D status, and relatively short follow-up periods. Vitamin D exerts its action via the vitamin D receptor (VDR) at the molecular level. It affects the gene expression related to various functions such as the cell cycle, apoptosis, cellular differentiation, immune modulation, and inflammatory processes. Current scientific evidence supports a mechanism by which vitamin D3 could play a part in the prevention of cancer. However, clear clinical recommendations require further well-designed randomized controlled trials incorporating adequate supplementation doses and focusing on populations with vitamin D deficiency.
- Open Access
- 17 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (2(50))
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN PEDIATRIC HEMOLYTIC UREMIC SYNDROME: FREQUENCY, IMAGING PATTERNS, AND CLINICAL OUTCOMES
Background: Hemolytic uremic syndrome (HUS) is the leading cause of typical thrombotic microangiopathy in children, most commonly triggered by Shiga toxin–producing Escherichia coli (STEC). Beyond the classic triad of microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury, central nervous system (CNS) involvement is a major determinant of severity. Methods: Narrative synthesis of clinical, epidemiologic, and neurodiagnostic literature addressing pediatric HUS with CNS involvement. Results: Neurological complications in STEC-HUS occur in approximately the low-teens in contemporary cohorts and most often present with seizures and encephalopathy; PRES, focal deficits, movement disorders, and cerebrovascular complications are less frequent but clinically significant. STEC-HUS is initiated by Shiga toxin–mediated endothelial injury leading to thromboinflammation and microvascular thrombosis, while complement activation likely amplifies endothelial damage and contributes to CNS vulnerability. In aHUS, neurological involvement is more frequent and reflects systemic complement-mediated microangiopathy. MRI, particularly diffusion-weighted imaging and ADC mapping helps differentiate microangiopathic injury from PRES or infarction/hemorrhage and may support early risk stratification. EEG is useful for detecting epileptic activity and subclinical encephalopathy. Management is predominantly supportive and neurocritical (seizure control, blood pressure management, correction of metabolic derangements, and renal support). Eculizumab is essential in aHUS but remains controversial in STEC-HUS, with no consistent neurological benefit over standard care in recent syntheses. Conclusions: CNS involvement identifies a high-risk pediatric HUS subgroup requiring early neurologic assessment, targeted MRI/EEG use, meticulous critical care, and structured long-term follow-up due to potential subtle neurocognitive sequelae.
- 17 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (2(50))
Open AccessCENTRAL NERVOUS SYSTEM INVOLVEMENT IN PEDIATRIC HEMOLYTIC UREMIC SYNDROME: FREQUENCY, IMAGING PATTERNS, AND CLINICAL OUTCOMES
Background: Hemolytic uremic syndrome (HUS) is the leading cause of typical thrombotic microangiopathy in children, most commonly triggered by Shiga toxin–producing Escherichia coli (STEC). Beyond the classic triad of microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury, central nervous system (CNS) involvement is a major determinant of severity. Methods: Narrative synthesis of clinical, epidemiologic, and neurodiagnostic literature addressing pediatric HUS with CNS involvement. Results: Neurological complications in STEC-HUS occur in approximately the low-teens in contemporary cohorts and most often present with seizures and encephalopathy; PRES, focal deficits, movement disorders, and cerebrovascular complications are less frequent but clinically significant. STEC-HUS is initiated by Shiga toxin–mediated endothelial injury leading to thromboinflammation and microvascular thrombosis, while complement activation likely amplifies endothelial damage and contributes to CNS vulnerability. In aHUS, neurological involvement is more frequent and reflects systemic complement-mediated microangiopathy. MRI, particularly diffusion-weighted imaging and ADC mapping helps differentiate microangiopathic injury from PRES or infarction/hemorrhage and may support early risk stratification. EEG is useful for detecting epileptic activity and subclinical encephalopathy. Management is predominantly supportive and neurocritical (seizure control, blood pressure management, correction of metabolic derangements, and renal support). Eculizumab is essential in aHUS but remains controversial in STEC-HUS, with no consistent neurological benefit over standard care in recent syntheses. Conclusions: CNS involvement identifies a high-risk pediatric HUS subgroup requiring early neurologic assessment, targeted MRI/EEG use, meticulous critical care, and structured long-term follow-up due to potential subtle neurocognitive sequelae.
- Open Access
- 15 May 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (2(50))
STRESS FRACTURES OF THE FEMORAL NECK IN PHYSICALLY ACTIVE INDIVIDUALS: DIAGNOSTIC CHALLENGES AND MANAGEMENT
Stress fractures of the femoral neck are rare but potentially serious conditions. They primarily affect physically active individuals. The aim of this study was to summarize the current state of knowledge regarding stress fractures of the femoral neck, with particular emphasis on diagnostic challenges and current treatment methods. An analysis of the available scientific literature was conducted, covering epidemiology, pathophysiology, clinical presentation, diagnosis, and therapeutic management. Stress fractures are relatively rare but are associated with a high risk of complications, especially in cases of delayed diagnosis. Diagnosis of this type of injury is often delayed due to nonspecific symptoms, such as progressive pain in the groin or hip area that worsens during physical activity. Delayed diagnosis is also contributed to by the reduced sensitivity of radiological examinations in the early stages of the condition. Magnetic resonance imaging (MRI) is the method of choice for diagnosis, enabling the detection of lesions at an early stage and the assessment of their severity. Classifying fractures as compression or tension fractures is crucial for selecting the appropriate treatment. Therapy may include both conservative and surgical management. Early diagnosis and appropriate treatment are crucial for a favorable prognosis and return to physical activity. Identifying and modifying risk factors plays an important role in preventing the occurrence and recurrence of fractures.
- 15 May 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (2(50))
Open AccessSTRESS FRACTURES OF THE FEMORAL NECK IN PHYSICALLY ACTIVE INDIVIDUALS: DIAGNOSTIC CHALLENGES AND MANAGEMENT
Stress fractures of the femoral neck are rare but potentially serious conditions. They primarily affect physically active individuals. The aim of this study was to summarize the current state of knowledge regarding stress fractures of the femoral neck, with particular emphasis on diagnostic challenges and current treatment methods. An analysis of the available scientific literature was conducted, covering epidemiology, pathophysiology, clinical presentation, diagnosis, and therapeutic management. Stress fractures are relatively rare but are associated with a high risk of complications, especially in cases of delayed diagnosis. Diagnosis of this type of injury is often delayed due to nonspecific symptoms, such as progressive pain in the groin or hip area that worsens during physical activity. Delayed diagnosis is also contributed to by the reduced sensitivity of radiological examinations in the early stages of the condition. Magnetic resonance imaging (MRI) is the method of choice for diagnosis, enabling the detection of lesions at an early stage and the assessment of their severity. Classifying fractures as compression or tension fractures is crucial for selecting the appropriate treatment. Therapy may include both conservative and surgical management. Early diagnosis and appropriate treatment are crucial for a favorable prognosis and return to physical activity. Identifying and modifying risk factors plays an important role in preventing the occurrence and recurrence of fractures.